Trials / Completed
CompletedNCT00002022
Treatment Program for Anemia in AIDS Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- R W Johnson Pharmaceutical Research Institute · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the Eprex (erythropoietin) Treatment Program is to provide erythropoietin for the treatment of anemia in AIDS patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Epoetin alfa |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2005-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00002022. Inclusion in this directory is not an endorsement.